Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1359L |
Amyloid β Peptide (42-1)(human) acetate
Amyloid β Peptide (42-1)(human) acetate(317366-82-8 free base) |
Beta Amyloid | Neuroscience |
Amyloid β Peptide (42-1)(human) acetate 是淀粉样蛋白 β 肽 (1-42) 的无活性形式。Amyloid β Peptide (42-1)(human) acetate 是由 42 个氨基酸组成的肽,其在阿尔茨海默病的发病机制中起关键作用。 | |||
T35499 |
β-Amyloid (1-42), (rat/mouse) (TFA)
Amyloid β-peptide (1-42) (human) TFA,166090-74-0 TFA |
||
β-Amyloid (1-42), (rat/mouse) (TFA) 是由 42 个氨基酸组成的多肽片段,可用于研究阿尔茨海默症。 | |||
T32106 |
Human beta-amyloid protein 42 (1-7)
Vanutide |
||
Human beta-amyloid protein 42 (1-7) is a bioactive chemical. | |||
TP1359 |
β-Amyloid (42-1), human
Amyloid β Peptide (42-1)(human) |
||
β-Amyloid (42-1), human is the inactive form of Amyloid β Peptide (1-42) which plays a key role in the pathogenesis of Alzheimer disease. | |||
TP1007 |
β-Amyloid (1-42), human
大豆肽,β-Amyloid (1-42), human,Amyloid β-Peptide (1-42) human |
Beta Amyloid | Neuroscience |
β-Amyloid (1-42), human 是一种由 42 个氨基酸组成的肽,在阿尔茨海默病的发病机制中起关键作用。 | |||
T38149 |
β-Amyloid (1-43)(human)
|
||
The amyloid β-protein is a 39- to 43-amino acid polypeptide that is the primary constituent of senile plaques and cerebrovascular deposits in Alzheimer's disease and Down's syndrome. Additionally it acts as an inhibitor of the ubiquitin-dependent protein degradation in vitro. | |||
T37768 |
β-Amyloid (1-37) (human)
|
||
β-Amyloid (1-37) (human) 与阿尔茨海默病的精神状态有潜在关联。 | |||
T37370 |
Amyloid-β (25-35) Peptide (human) (trifluoroacetate salt)
|
||
Amyloid-β (25-35) (Aβ (25-35)) is an 11-residue fragment of the Aβ protein that retains the physical and biological characteristics of the full length peptide. It forms fibrils that react to thioflavin T and Congo red and are organized in a cross-β arrangement of β-strands similar to Aβ (1-40) and Aβ (1-42) fibrils. Aggregated Aβ (25-35) decreases the viability of rat adrenal PC12 cells. It also decreases the viability of primary rat cortical neurons at concentrations ranging from 1 nM to 30 μM.... | |||
T77042 |
Aducanumab
BIIB037 |
Beta Amyloid | Neuroscience |
Aducanumab (BIIB037),一种选择性人免疫球蛋白γ-1(IgG1)单克隆抗体,靶向β淀粉样蛋白 (Aβ) 的聚集形式。Aducanumab 显示出脑渗透性,可用于治疗阿尔茨海默病 (AD) 。 | |||
T13253 |
Umibecestat
CNP520 |
BACE | Neuroscience |
Umibecestat 是一种β-位点淀粉样前体蛋白裂解酶-1 (BACE-1) 抑制剂,对人 BACE-1 和小鼠 BACE-1 的 IC50 分别为 11 nM 和 10 nM,可用于阿尔茨海默病的研究。 | |||
T31828 |
AZD4694
Flutafuranol,AZD 4694,NAV-4694,AZD-4694,NAV 4694,NAV4694 |
||
Flutafuranol, also known as AZD 4694 and NAV4694, is a bio-active chemical. AZD4694 shows high affinity for beta-amyloid fibrils in vitro (K(d) = 2.3 +/- 0.3 nM). The fluorine-18 labeled AZD4694 may have potential for PET-visualization of cerebral beta-am | |||
T80701 |
β Amyloid (1-16) rat
|
||
β-Amyloid (1-16) rat 是β-淀粉样肽 (Abeta) 金属结合域的片段,含有三个与人类相异的氨基酸替代,因此在大鼠和小鼠中降低了 AD 样神经退行性变的易感性。 | |||
T82242 | hAChE-IN-6 | ||
hAChE-IN-6(化合物51)是一种能够穿透血脑屏障的AChE抑制剂,具有0.16 μM的IC50。该化合物同时对hBuChE与GSK3β显示出抑制活性,其IC50分别为0.69 μM和0.26 μM。hAChE-IN-6亦能抑制tau蛋白与Aβ1-42的自聚集,适用于阿尔茨海默病(AD)的相关研究。 | |||
T82243 | hAChE-IN-5 | GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
hAChE-IN-5(化合物49)是一种同时针对hAChE和hBuChE的有效抑制剂,其IC50值均为0.17 μM。此外,hAChE-IN-5对GSK3β同样展现出良好的抑制活性,IC50值为0.21 μM。作为tau蛋白聚集和Aβ1-42自聚集的抑制剂,hAChE-IN-5能够结合PAS,进而阻止Aβ依赖的神经毒性。其能穿透血脑屏障(BBB),显示出成为多靶点抗阿尔茨海默病药物研究的潜力。 |